Pfizer (PFE)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-14 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: PFIZER INC (PFE) CIK: 0000078003 --- Reporting Owner --- Name: BOURLA ALBERT CIK: 0001595703 Role: Director, Officer (Chairman & CEO) --- Derivative Transactions --- [Transaction #1] Security: Phantom Stock Units SSP Date: 2026-08-14 | Code: A (Grant or award) Shares: +22 | Price: $26.79 Shares Owned After: 785,060 | Ownership: D (Direct) Footnotes: [F1] Each unit represents one phantom share of common stock. [F2] These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. [F2] These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. --- Footnotes (Complete Index) --- F1: Each unit represents one phantom share of common stock. F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. --- Signature --- /s/ /s/ Shanice A. Reid, by power of atty., for Albert Bourla (2026-08-17)